Longitudinal Characterisation of B- and T-Cell Immune Responses After a Booster Dose of the COVID-19 mRNA Vaccine in People With MS on Different Disease-Modifying Therapies
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of Neurology, Neurosurgery, and Psychiatry
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Longitudinal characterisation of B and T-cell immune responses after the booster dose of COVID-19 mRNA-vaccine in people with multiple sclerosis using different disease-modifying therapies
J. Neurol. Neurosurg. Psychiatr. 2022 Dec 15;[EPub Ahead of Print], A Aiello, A Coppola, S Ruggieri, C Farroni, AMG Altera, A Salmi, V Vanini, G Cuzzi, L Petrone, S Meschi, D Lapa, A Bettini, S Haggiag, L Prosperini, S Galgani, ME Quartuccio, N Bevilacqua, AR Garbuglia, C Agrati, V Puro, C Tortorella, C Gasperini, E Nicastri, D GolettiFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.